Source: Eur Respir J 2016; 47: 382-384



Rating:

Share or cite this content

Citations should be made in the following way:
Guan Wei-jie, Chen Rong-chang, Zhong Nan-shan. The bronchiectasis severity index and FACED score for bronchiectasis. Eur Respir J 2016; 47: 382-384

Member's Comments

No comment yet.

Related content which might interest you: The bronchiectasis severity index (BSI) and FACED score for assessment the severity of bronchiectasis Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study Source: Eur Respir J 2016; 47: 482-489 Year: 2016 Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score Source: Eur Respir J 2014; 43: 1357-1367 Year: 2014 The derivation of a new index of severity for COPD patients, the DOSE index: MRC dyspnea scale, airflow obstruction, smoking status and exacerbations Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 How to assess the severity of bronchiectasis Source: Eur Respir J 2014; 43: 1217-1219 Year: 2014 Exercise capacity is related with FACED score for disease severity in non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy Year: 2016 Small-airway dysfunction among non-cystic bronchiectasis patients with different Bronchiectasis Severity Index Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis. Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Which score is better in association with exercise capacity and QoL in noncystic fibrosis bronchiectasis patients? FACED or BSI? Source: International Congress 2019 – Bronchiectasis Year: 2019 Correlation study of semi-quantitative CT emphysema score with the BODE index in COPD patients Source: Annual Congress 2009 - Functional insights into COPD Year: 2009 Dyspnoea, obstruction, smoking and exacerbation (DOSE) index and mortality in COPD Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011 Symptom duration and the lung clearance index in children with cystic fibrosis and pulmonary exacerbations Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Bronchiectasis exacerbations risk prediction using severity scales BSI and FACED Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Improved spirometric index to discriminate the severity of centrilobular emphysema Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 Modified pulmonary index score (MPIS) and indication of hospitalization for acute asthma exacerbation in children Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 ²DOSE² index in severe COPD Source: Eur Respir J 2007; 30: Suppl. 51, 97s Year: 2007 The clinical importance of centrilobular enfisema in COPD patients: its impact on the BODE index. Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 The bronchiectasis ‘bacteriophagome’ Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021 Immunodeficits in bronchiectasis Source: International Congress 2017 – PG3 Bronchiectasis Year: 2017